Technical Report Genetics Nutrition
Effect of an antibiotic stewardship programme on acute kidney injury among patients on haemodialysis

Effect of an antibiotic stewardship programme on acute kidney injury among patients on haemodialysis

Authors

Sarah Andersen

Sarah Andersen

Royal Melbourne Hospital, Tajikistan

Corresponding

Published

May 24, 2025

Paper ID

PAP-000242

Status

Published

DOI

10.65712/tmj.test000500

Effect of an antibiotic stewardship programme on acute kidney injury among patients on haemodialysis

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Practice around an antibiotic stewardship programme varies widely between centres. Methods: We conducted a case series across 13 centres between 2019 and 2023. Results: Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. Conclusion: Residual confounding cannot be excluded.

Introduction

Practice around an antibiotic stewardship programme varies widely between centres. The cost of acute kidney injury to health systems is substantial.

acute kidney injury remains a leading cause of avoidable harm among patients on haemodialysis. Guidelines make only a weak recommendation on an antibiotic stewardship programme. Earlier studies of an antibiotic stewardship programme were small or single-centre.

The cost of acute kidney injury to health systems is substantial. Guidelines make only a weak recommendation on an antibiotic stewardship programme. acute kidney injury remains a leading cause of avoidable harm among patients on haemodialysis.

Discussion

Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.

Conclusions

An antibiotic stewardship programme is a reasonable option for patients on haemodialysis to improve acute kidney injury.

References

1. Schmidt F, Okafor K, et al. SGLT2 inhibitors and glycaemic control. BMJ. 2017;332(9):447-1749.

2. Nasser M, Nakamura I, et al. Low-dose aspirin and acute kidney injury. JAMA. 2009;212(8):134-1542.

3. Dubois E, Novak T, et al. Nurse-led discharge planning and chronic pain scores. Crit Care Med. 2021;158(5):654-1356.

4. Costa C, Okafor C, et al. Early enteral nutrition and length of stay. Pediatrics. 2022;67(7):500-1206.

5. Mueller C, Lindqvist R, et al. Continuous glucose monitoring and in-hospital mortality. Diabetes Care. 2023;239(4):480-1172.

6. Kowalski R, Haddad M, et al. Prone positioning and 30-day readmission. Diabetes Care. 2022;160(2):664-1062.

7. Mueller Y, Haddad K, et al. Tranexamic acid and ventilator-free days. BMC Med. 2008;297(9):350-1777.

8. Volkov H, Kowalski G, et al. Telemedicine follow-up and length of stay. Lancet. 2022;323(6):429-1133.

Appendices

Supplementary tables are available on request.

Materials and Methods

We conducted a case series across 12 centres between 2014 and 2022. We conducted a case series across 14 centres between 2016 and 2022. The primary outcome was acute kidney injury, assessed blind to allocation.

Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.

Results

803 participants were included (median age 78 years). acute kidney injury occurred in 7% of the intervention group versus 31% of controls. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.77 (95% CI 0.26 to 0.72).

Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.39 (95% CI 0.42 to 0.97). The adjusted odds ratio was 0.82 (95% CI 0.36 to 0.85).

Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. 2272 participants were included (median age 36 years).

GroupnEventsRate %
Centre A2577335.9
Age ≥ 65662931.5
Control4599339.9
Centre A8407621.1
Centre A1071164.0
Intervention4724019.4
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in acute kidney injury
Shown for patients on haemodialysis; error bars are 95% confidence intervals.

4233 participants were included (median age 73 years). acute kidney injury occurred in 16% of the intervention group versus 23% of controls.

Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.50 (95% CI 0.38 to 0.65).